Placental alkaline phosphatase in pediatric adrenocortical cancer

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 4, 2011, Pages

  Boechat, Giovanna Assis Pereira ^a,b   Stinghen, Sérvio Túlio ^a,b   Custódio, Gislaine ^a,b   Pianovski, Mara Albonei Dudeque ^a,b   Figueiredo, Francisco Ricardo De Oliveira ^a   Jenkins, Jesse ^c   Zambetti, Gerard P ^c   Ribeiro, Raul C ^c,d   Figueiredo, Bonald C ^a,b  

^a Center for Molecular Genetics and Cancer Research in Children (CEGEMPAC)   (Brazil)

^b INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^c Department of Pathology ^*  (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

adrenal; adrenocortical cancer; children; placental alkaline phosphatase; suprarenal

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; PROTEIN P53;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ARTICLE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; GENE EXPRESSION; GENE MUTATION; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ALKALINE PHOSPHATASE; APOPTOSIS; CHILD; FEMALE; GERM-LINE MUTATION; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955509664     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182099a80     Document Type: Article

References (50)

1. Rodriguez-Galindo C, Figueiredo BC, Zambetti G, et al. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer. 2005;45: 265-273. (Pubitemid 41077159)
2. Michealkiewicz E, Sandrini R, Figueiredo BC, et al. Clinical and outcome characteristics of children with adrenocortical tumors. An analysis of 254 cases from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004; 22:838-845. (Pubitemid 41103595)
3. Birch JM, Blair V. Increase in childhood carcinomas in northwest England [Letter]. Lancet. 1988;1:833. (Pubitemid 18094952)
4. Desandes E, Clavel J, Berger C, et al. Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer. 2004; 43:749-757. (Pubitemid 39557711)
5. Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms. In: Ries LAG, Smith MA, Gurney JG, et al. eds. Cancer and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999:139-147.
6. Pianovski MAD, Maluf EMCP, Carvalho DS, et al. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil. Pediatr Blood Cancer. 2006;47:56-60. (Pubitemid 43787909)
7. Figueiredo BC, Sandrini R, Zambetti GP, et al. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet. 2006;43:91-96. (Pubitemid 43099998)
8. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A. 2001;98:9330-9335. (Pubitemid 32743916)
9. Pianovski MA, Cavalli LR, Figueiredo BC. SF-1 overexpression in childhood adrenocortical tumours. Eur J Cancer. 2006; 42:1040-1043.
10. West AN, Neale GA, Pounds S, et al. Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 2007;67:600-608. (Pubitemid 46192198)
11. Longui CA, Lemos-Marni SH, Figueiredo B, et al. Inhibin alpha-subunit (INHA) gene and locus changes in pediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers. J Med Genet. 2004;41:354-359. (Pubitemid 38608518)
12. Millán JL, Fishman WH. Biology of human alkaline phosphatases with special reference to cancer. Crit Rev Clin Lab Sci. 1995;32:1-39.
13. Kosmas C, Kalofonos H, Hird V, et al. Monoclonal antibody targeting of ovarian carcinoma. Oncology. 1998;55:435-446. (Pubitemid 28396056)
14. Hamilton-Dutoit S, Lou H, Pallesen G. The expression of placental alkaline phosphatases (PLAP) and PLAP-like enzymes in normal and neoplastic human tissues. An immunohistological survey using monoclonal antibody. APMIS. 1990; 98:797-811. (Pubitemid 20335491)
15. Nouri AME, Torabi-Pour N, Dabare AA. A new highly specific monoclonal antibody against placental alkaline phosphatase: a potential marker for the early detection of testis tumour. BJU Int. 2000;86:894-900.
16. Low MG, Finean JB. Release of alkaline phosphatase from membranes by a phosphatidylinositol-specific phospholipase. Biochem J. 1977;167:281-284. (Pubitemid 8217012)
17. Yusufi AN, Low MG, Turner ST, et al. Selective removal of alkaline phosphatase from renal brushborder membrane and sodium-dependent brush-border membrane transport. J Biol Chem. 1983;258:5695-5701. (Pubitemid 13096491)
18. Schwartz JH, Lipmann F. Phosphate incorporation into alkaline phosphatase of E. coli. Proc Natl Acad Sci U S A. 1961;47:1996-2005.
19. Nakayama T, Yoshida M, Kitamura M. L-leucine sensitive, heat-stable alkaline phosphatase isoenzyme detected in a patient with pleuritis carcinomatosis. Clin Chim Acta. 1970;30: 546-548.
20. Doellgast GH, Fishman WH. L-leucine, a specific inhibitor of a rate human placental alkaline phosphatase phenotype. Nature. 1976;259:49-51.
21. McLaughlin PJ, Johnson PM. A Search for Human Placentaltype Alkaline Phosphatases Using Monoclonal Antibodies. New York: Alan R. Liss Inc; 1984;67-75.
22. De Broe ME, Pollet DE. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum. Clin Chem. 1988;34:1995-1999.
23. Fisken J, Leonard RC, Shaw G, et al. Serum placental-símile alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer. J Clin Pathol. 1989;42:40-45. (Pubitemid 19036905)
24. Weissbach L, Bussar-Maatz R, Mann K. The value of tumor markers in testicular seminomas. Eur Urol. 1997;32:16-22.
25. Goldstein DJ, Rogers CE, Harris H. Evolution of alkaline phosphatase in primates. Proc Natl Acad Sci U S A. 1982; 79:879-883.
26. McLaughlin PJ, Travers PJ, McDicken IW, et al. Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. Clin Chim Acta. 1984; 137:341-348. (Pubitemid 14139962)
27. Franke FE, Pauls K, Rey R, et al. Differentiation markers of Sertolli cells and germ cells in fetal and early postnatal human testis. Anat Embryol (Berl). 2004;309:169-177. (Pubitemid 40100857)
28. Millán JL, Eriksson A, Stigbrand T. A possible new locus of alkaline phosphatase expressed in human testis. Hum Genet. 1982;62:293-295. (Pubitemid 13117084)
29. Fishman WH, Ghosh NK, Inglis NR, et al. Quantitation of the placental isoenzyme of alkaline phosphatase in pregnancy sera. Enzymologia. 1968;34:317-321.
30. Fishman WH, Inglis NR, Green S, et al. Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature. 1968;219:697.
31. Fishman L, Miyayama H, Driscoll SG, et al. Developmental phase-specific alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res. 1976;36:2268-2273.
32. Pollet DE, Nouwen EJ, Schelstraete JB, et al. Enzyme-antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts as tumor marker. Clin Chem. 1985; 31:41-45. (Pubitemid 15079342)
33. Jacobs EL, Haskell MC. Clinical use of tumor markers in oncology. Curr Probl Cancer. 1991;15:299-360.
34. Loose JH, Damjanov I, Harris H. Identity of the neoplastic alkaline phosphatase as revealed with monoclonal antibodies to the placental form of the enzyme. Am J Clin Pathol. 1984; 82:173-177. (Pubitemid 14060387)
35. Nathanson L, Fishman W. New observations on the Reagan isoenzyme of alkaline phosphatase in cancer patients. Cancer. 1971;27:1388-1397.
36. Mori R, Nakajima M, Sakai H, et al. Pineal germinoma with a prominent epithelioid cell granuloma component: case report. Neurol Med Chir (Tokyo). 2008;48:573-575.
37. Ohta Y, Suzuki T, Tonoike T, et al. Two cases of intracranial germinoma showing a cell arrangement mimicking carcinoma. Diagn Cytopathol. 2010;38:32-136.
38. Wang F, Liu A, Peng Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009;33:1529-1539.
39. Roelofs H, Manes T, Janszen T, et al. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumors: an enzyme-/immunohistochemical and molecular analysis. J Pathol. 1999;189:236-244. (Pubitemid 29448919)
40. Hoylaerts MF, Ding L, Narisawa S, et al. Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochemistry. 2006;45:9756-9766. (Pubitemid 44257423)
41. De Groote G, De Waele P, Van de Voorde A, et al. Use of monoclonal antibodies to detect human placental alkaline phosphatase. Clin Chem. 1983;29:115-119. (Pubitemid 13167632)
42. Maslow WC, Muensch HA, Azama F, et al. Sensitive fluorometry of heat stable alkaline phosphatase (Regan enzyme) in serum from smokers and non-smokers. Clin Chem. 1983;29:260-263. (Pubitemid 13138284)
43. Williams GH, McLaughlin PJ, Johnson PM. Tissue origin of serum placental-símile alkaline phosphatase in cigarette smokers. Clin Chim Acta. 1986;155:329-334. (Pubitemid 16055483)
44. Stinghen ST, Moura JF, Zancanella P, et al. Specific immunoassays for placental alkaline phosphatase as a tumor marker. J Biomed Biotechnol. 2006;1-8.
45. Le Du MH, Stigbrand T, Taussig MJ, et al. Crystal structure of alkaline phosphatase from human placenta at 1.8 Å resolution. J Biol Chem. 2001;276:9158-9165.
46. Lehto MT, Sharom FJ. Proximity of the protein moiety of a GPI-Anchored protein to the membrane surface: a FRET study. Biochemistry. 2002;41:8368-8376. (Pubitemid 34705490)
47. Eriksson HJC, Somsen GW, Hinrichs WLJ, et al. Characterization of human placental alkaline phosphatase by activity and protein assays, capillary electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Chromatogr B Biomed Sci Appl. 2001;755: 311-319. (Pubitemid 32324098)
48. Lanier M, Sergienko E, Simão AM, et al. Design and synthesis of selective inhibitors of placental alkaline phosphatase. Bioorg Med Chem. 2010;18:573-579.
49. Ben-Arie A, Hagay Z, Ben-Hur H, et al. Elevated serum alkaline phosphatase may enable early diagnosis of ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 1999;86: 69-71. (Pubitemid 29333252)
50. Koshida K, Uchibayashi T, Yamamoto H, et al. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma. Br J Urol. 1996;77:138-142.